2seventy bio, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c5f0f9c6-9c32-40f0-9953-046f3db24a95/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $37.9M | 2024-01-01 – 2024-12-31 | evidence 0001860782-25-000024 |
| FY 2023 | $100.4M | 2023-01-01 – 2023-12-31 | evidence 0001860782-24-000027 |
| FY 2022 | $91.5M | 2022-01-01 – 2022-12-31 | evidence 0001860782-23-000038 |
| FY 2021 | $54.5M | 2021-01-01 – 2021-12-31 | evidence 0001860782-22-000005 |
| FY 2020 | $248.1M | 2020-01-01 – 2020-12-31 | evidence 0001860782-22-000005 |
| FY 2019 | $44.3M | 2019-01-01 – 2019-12-31 | evidence 0001860782-22-000005 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
2seventy bio, Inc. — all facts · Net Income · Operating Income